Jobs filters
DIVISION CHIEF | THORACIC MEDICAL ONCOLOGY | DUARTE, CA - 10026006
Duarte, CAHEAD AND NECK SURGEON WITH RECONSTRUCTIVE EXPERIENCE AND EMPHASIS (FELLOWSHIP-TRAINED) - 10026288
Duarte, CAPHYSICIAN | NON-INVASIVE CARDIOLOGIST | GOODYEAR, AZ - JR-11486
Phoenix, AZPATIENT CARE ASSISTANT I - 10026054
Duarte, CAPHYSICIAN LEADER| CHAIR, DEPARTMENT OF PATHOLOGY | DUARTE, CA - 10025496
Duarte, CASENIOR SITE LIAISON - PATIENT ACCESS (DUARTE) - 10025611
Duarte, CAPATIENT CARE ASSISTANT I - 10024970
Duarte, CAMEDICAL ASSISTANT II - 10021456
Duarte, CAMEDICAL ASSISTANT I - 10025680
Irvine, CASTAFF SCIENTIST - IMMUNE SIGNALING AND CAR T CELL BIOLOGY - 10025448
Duarte, CAIT PROJECT MANAGER - HEALTHCARE HYBRID - 10025495
Irvine, CARESEARCH ASSOCIATE I - HEMATOPOIETIC TISSUE BIOREPOSITORY - 10025001
Orange, CA
STAFF SCIENTIST - CAR T RESEARCH - 10024476
Duarte, CACity of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research.
The Arthur Giggs Diabetes & Metabolism Research Institute (AR-DMRI) promotes new discoveries and innovation across pathophysiology, diabetes related complications and treatment of type 1 and 2 diabetes. The Department of Translational Research & Cellular Therapeutics (TRCT) which is under AR-DMRI, led by Fouad Kandeel, M.D., Ph.D., has translated landmark scientific discoveries into treatments that have improved the lives of diabetic patients around the world. TRCT focuses on stem cell biology and development, translational and clinical research, islet isolation and distribution, islet isolation and quality assessment, islet imaging, islet encapsulation, and new drug discoveries.
The Staff Scientist series is designed for career research professionals whose primary function is to support the research infrastructure and activities of the institution. Staff Scientists will bring special skills, knowledge and experience to research programs or institutional core laboratories. Individuals appointed as staff scientists will receive a one-year fixed-term contract.
Your qualifications should include:
- A Ph.D with a minimum of three years of human T cells and regulatory T cells research experience.
- Must have the ability to design and execute laboratory experiments, critically interpret experimental results, and present data in a clear and concise manner.
- Ability to participate in the preparation of grant applications, scientific publications, and IND submissions.
- Excellent oral and written communication skills. Demonstrated publication record in peer-reviewed scientific journals.
Preferred qualifications:
- Proficiency in immunology and diabetes research, particularly Type 1 Diabetes (T1D).
- Expertise in the development of Chimeric Antigen Receptor T (CAR-T) cells.
- Ability to effectively develop projects in a translational research environment to meet project goals.
City of Hope is an equal opportunity employer. To learn more about our commitment to diversity, equity and inclusion, please click here.
To learn more about our Comprehensive Benefits, please CLICK HERE.